From: Body mass index (BMI) may be a prognostic factor for gastric cancer with peritoneal dissemination
Variables | n | 1-year survival rate (%) | Median survival (months) | p value |
---|---|---|---|---|
All 518 gastric cancer patients with peritoneal dissemination | ||||
Palliative gastrectomy | <0.001 | |||
With | 330 | 19 | 7.33 | |
Without | 188 | 31 | 16.13 | |
Tumor size | <0.001 | |||
<5 cm | 188 | 31 | 17.30 | |
5 and <10 cm | 243 | 26 | 11.00 | |
>10 cm | 87 | 18 | 9.30 | |
Tumor location | 0.011 | |||
Upper | 118 | 23 | 12.00 | |
Middle | 105 | 30 | 15.60 | |
Lower | 191 | 39 | 13.33 | |
Total | 104 | 20 | 8.97 | |
Peritoneal seeding grade | <0.001 | |||
P1 | 136 | 34 | 18.67 | |
P2 | 149 | 31 | 15.48 | |
P3 | 233 | 19 | 8.97 | |
Ascite | 0.001 | |||
With | 207 | 20 | 9.87 | |
Without | 311 | 31 | 14.27 | |
Serum CEA level (ng/ml) | 0.002 | |||
Normal | 349 | 29 | 14.03 | |
Elevated | 142 | 20 | 9.33 | |
Serum CA19-9 level (U/ml) | 0.033 | |||
Normal | 314 | 29 | 13.53 | |
Elevated | 169 | 22 | 11.27 | |
Palliative chemotherapy | <0.001 | |||
Yes | 337 | 35 | 17.40 | |
No | 181 | 9 | 6.90 | |
BMI group (kg/m2) | <0.001 | |||
<18.5 | 167 | 15 | 8.17 | |
18.5–23 | 232 | 35 | 18.67 | |
>23 | 119 | 25 | 11.87 |